symmetric dimethylarginine has been researched along with bisoprolol in 1 studies
Studies (symmetric dimethylarginine) | Trials (symmetric dimethylarginine) | Recent Studies (post-2010) (symmetric dimethylarginine) | Studies (bisoprolol) | Trials (bisoprolol) | Recent Studies (post-2010) (bisoprolol) |
---|---|---|---|---|---|
428 | 27 | 314 | 1,249 | 392 | 496 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egashira, K; Ito, A; Muramatsu, K; Narishige, T; Takeshita, A | 1 |
1 trial(s) available for symmetric dimethylarginine and bisoprolol
Article | Year |
---|---|
Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arginine; Bisoprolol; Blood Pressure; Endothelium, Vascular; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide Synthase; Perindopril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; von Willebrand Factor | 2001 |